GoldBamboo.com - Knowledge is strong medicine
  

Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:






Electrodermal screening

 




Clinical Trial: Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening

This study is currently recruiting patients.
Verified by Centers for Disease Control and Prevention August 2005

Sponsors and Collaborators: Centers for Disease Control and Prevention
University of Texas Health Science Center at Houston
Information provided by: Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT00137618

Purpose

This project is a community based participatory research collaboration that will enable us increase Informed Decision Making (IDM) for prostate cancer screening in Hispanic and African American men. This will be done through the development of an educational program implemented in the communities of El Paso, Texas and Columbia, South Carolina to provide accurate information to men regarding prostate cancer screening in order to enable them to make informed decisions.
Condition Intervention
Prostatic Neoplasm
Prostate Cancer
 Behavior: Educational Intervention to Increase Informed Decision Making for Prostate Cancer Screening

MedlinePlus related topics:  Prostate Cancer

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Active Control, Single Group Assignment

Official Title: Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening - Univ of Texas - SIP 21-04

Further Study Details: 
Primary Outcomes: A comparison of pre- and post-test regarding prostate cancer screening knowledge will be assessed quantitatively. The pre-test will be administered before the intervention is implemented and the post-test will be administered immediately followin
Secondary Outcomes: This will include whether or not the participant has decided to have the prostate cancer screening test called prostate specific antigen and if they actually complete it. This will be measured several months after the intervention.
Expected Total Enrollment:  264

Study start: November 2004;  Expected completion: September 2007
Last follow-up: October 2006;  Data entry closure: June 2007

This project is a community based participatory research collaboration among two universities and two research networks that will enable us increase Informed Decision Making (IDM) for prostate cancer screening in Hispanic and African American men. Our collaborating universities are the University of Texas Health Science center at Houston, Texas Prevention Research Center (TPRC), Baylor College of Medicine (BCM), and the University of South Carolina (USC). Our collaborating networks are the Latinos in a Network for Cancer Control (LINCC), and the South Carolina Cancer Research Network (SC-CRN). Through the LINCC and the SCCRN, we have been able to link to the Cancer and Chronic Disease Consortium (CCDC, El Paso) which is working with Hispanic communities and the South Carolina Baptist Education and Missionary Convention (BEMC) which is a network of African American churches. Following the quality criteria for inclusion in evidence reviews conducted by the Community Guide for Preventive Services, we will adapt existing interventions and evaluate the effectiveness of these community–based IDM interventions for prostate cancer screening through two different studies, one at each site. We will first perform formative qualitative research in Hispanic communities in El Paso, Texas and in African American communities in Columbia, South Carolina. We will review existing IDM programs and contextual factors pertinent for adoption and dissemination in these two groups. Using the formative research and the review, we will adapt existing materials for intervention development in each group. For each study, the interventions will be evaluated using a pre-post-test delayed intervention comparison group design. As primary outcomes, we will measure the effect of community-based IDM interventions on men’s knowledge of prostate cancer screening, participation in screening decisions at their desired level and whether participation was congruent with individual values and preferences in decision–making.

Eligibility

Ages Eligible for Study:  40 Years   -   70 Years,  Genders Eligible for Study:  Male

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  • Males from approximately 40 to 70 years old

Exclusion Criteria:

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00137618

Jessica A Calderon, MPH      (915) 747-8579    Jessica.A.Calderon@uth.tmc.edu
Evelyn Chan, MD, MS      (713) 500-6705    Evelyn.C.Chan@uth.tmc.edu

South Carolina
      University of South Carolina, Arnold School of Public Health, Columbia,  South Carolina,  29208,  United States; Recruiting
John R Ureda, DrPH, MPH  803-765-2010    jureda@sc.rr.com 
Heather Brandt, PhD, CHES  (803) 777-7676    hmbrandt@sc.edu 
John R Ureda, DrPH, MPH,  Sub-Investigator

Texas
      University of Texas Health Science Center at Houston, Center for Health Promotion and Prevention Research, Houston,  Texas,  77030,  United States; Recruiting
Evelyn Chan, MD, MS  713-500-6705    Evelyn.C.Chan@uth.tmc.edu 
Leona K Bartholomew, EdD, MPH  (713) 500-9630    Leona.K.Bartholomew@uth.tmc.edu 
Evelyn Chan, MD, MS,  Principal Investigator

      UT Houston School of Public Health, El Paso Regional Campus, El Paso,  Texas,  79902,  United States; Recruiting
Jessica A Calderon, MPH  915-747-8579    Jessica.A.Calderon@uth.tmc.edu 
Theresa Byrd, DrPH, RN  (915) 747-8504    Theresa.L.Byrd@uth.tmc.edu 
Theresa Byrd, DrPH, RN,  Sub-Investigator

Study chairs or principal investigators

Evelyn Chan, MD, MS,  Principal Investigator,  University of Texas Health Science Center at Houston, Center for Health Promotion and Prevention Research   

More Information

Study ID Numbers:  CDC-NCCDPHP-2507
Last Updated:  August 29, 2005
Record first received:  August 26, 2005
ClinicalTrials.gov Identifier:  NCT00137618
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-30


[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Electrodermal screening.

November 29, 2009



Page Updated: January 17, 2009
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.